Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferndale IP, Inc. is the intellectual property holding company for the Ferndale Pharma Group, a family-owned healthcare organization headquartered in Ferndale, Michigan. Established as part of a corporate restructuring in 2004, the company manages a robust portfolio of trademarks and patents that support the group's commercial subsidiaries, including Ferndale Healthcare, Eloquest Healthcare, and Ferndale Laboratories. Its managed assets include well-known brands such as the L.M.X. line of topical anesthetics, Mastisol liquid adhesive, and RectiCare for anorectal conditions. Ferndale IP plays a critical role in the group's mission to provide specialized solutions in dermatology, surgical securement, and hospital-acquired infection prevention. The company's intellectual property underpins a wide range of over-the-counter and prescription products distributed globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferndale IP.